Patrick Mallory
Family Medicine · Loveland, CONPI 1164446514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 27.4% of the total.
Across 107 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$498
- AbbVie$409
- Amgen$124
- Pfizer$107
- Corium, LLC$104
- Lilly USA, LLC$79
- plus $497 from 17 others
What the payments were for
- Food & beverage$1,78798%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 40 | $498 |
| AbbVie(2 entities) | 20 | $409 |
| Amgen | 6 | $124 |
| Pfizer | 6 | $107 |
| Corium, LLC | 5 | $104 |
| Lilly USA, LLC | 5 | $79 |
| Novartis | 3 | $73 |
| Jazz Pharmaceuticals Inc. | 3 | $52 |
| Cleerly, Inc. | 2 | $51 |
| Exact Sciences | 2 | $40 |
| AstraZeneca | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Novo Nordisk | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Eisai Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $16 |
| Heartflow, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Antares Pharma, Inc. | 1 | $11 |
How this compares
$1,817 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 13 | $63,723 |
| Testosterone Cypionate | 91 | $6,574 |
| Liothyronine Sodium | 78 | $4,968 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $1,339 |
| Hydroxychloroquine Sulfate | 37 | $917 |
| Levothyroxine Sodium | 68 | $883 |
| Oxycodone Hcl | 19 | $746 |
| Anastrozole | 94 | $583 |
| Eszopiclone | 11 | $482 |
| Cefdinir | 15 | $456 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $411 |
| Tamsulosin Hcl | 28 | $384 |
| Tramadol Hcl | 27 | $377 |
| Allopurinol | 13 | $242 |
| Quetiapine Fumarate | 19 | $235 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Loveland
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
- Gregory MaederWestminster$95K
- Paul SimmonsGrand Junction$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.